-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Pharmaceutical company ImmunoPrecise recently released preliminary preclinical data showing that TATX-03 PolyTope antibody cocktail therapy specifically targeted at SARS-CoV-2 virus can remove 100% of the virus in hamsters.
results from previous preclinical studies show that TATX-03 PolyTope antibody cocktail therapy provides a powerful antiviral effect in preventing and treating SARS-CoV-2 infections.
TATX-03 PolyTope Antibody Cocktail Therapy is able to identify a variety of SARS-CoV-2 hedgehog proteins and has the potential to prevent virus mutations from escaping.
TATX-03 PolyTope antibody cocktail therapy was given in a single dose to hamsters infected with the SARS-CoV-2 variant.
that antibody cocktail therapy can completely remove replicable viruses on the fourth day after infection.
, studies have shown that the virus is not detected in 100% of hamster throats three days after infection.
TATX-03 PolyTope antibody cocktail therapy can also prevent SARS-CoV-2 infection in a preventive environment.
a single dose of TATX-03 PolyTope antibody mixture 24 hours before infecting hamsters with a SARS-CoV-2 variant can lead to a decrease in viral titration.